Jon Congleton, CEO: Mineralys Therapeutics MLYS Sell · Filed 24/06/20

Trade details

Type: Insider sale
Amount: $217,633.5
Shares · price: 17,766 sh · $12.25 a share
Held after: 958,505 sh
Stock: Mineralys Therapeutics MLYS
Person: Jon CongletonCEO
Trade date: 24/06/17
Filed: 24/06/20
Days to filing: 3 days

Sold 1.8% of holdings

Share of holding sold: 1.8%

Mineralys Therapeutics trades, last 26 weeks

What else happened in Mineralys Therapeutics around then

Filed or reported within 30 days of the trade day · 24/05/18~24/07/17

Jon Congleton's recent trades

Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$1.9M
75,000 sh
$1.9M
Filed 09/30
Traded 09/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$291.4K
10,700 sh
$291.4K
Filed 07/13
Traded 07/13
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$1.5M
58,000 sh
$1.5M
Filed 06/30
Traded 06/30
Jon CongletonCEO
Sell10b5-1 planMineralys Therapeutics
Sell10b5-1 plan
Mineralys Therapeutics
MLYS
$455.9K
17,000 sh
$455.9K
Filed 06/30
Traded 06/30
Jon CongletonCEO
Planned sale10b5-1 planMineralys Therapeutics
Planned sale10b5-1 plan
Mineralys Therapeutics
MLYS
$2M
75,000 sh
$2M
Filed 06/30
Traded 06/30

Jon Congleton, CEO — sold $217.6K of Mineralys Therapeutics MLYS · 1.8% of holdings · 10b5-1 plan | Whalegun